Mergers & Acquisitions
Davion Healthcare Agrees $13.5 Million Deal for Philadelphia Home Care Provider HSH
By News Desk ·
Key takeaways
- Davion Healthcare agreed to acquire Healthcare Stat Homecare Inc. for $13.5 million, comprising $8 million in cash and $5.5 million in Davion shares at $13 per share.
- HSH reported gross receipts of approximately $11.6 million and ordinary business income of approximately $1.9 million for the year ended December 31, 2025.
- Completion is expected on or before December 31, 2026, and Davion plans further acquisitions of profitable healthcare businesses over the coming year.
Davion Healthcare Plc agreed on October 27, 2026 to acquire Healthcare Stat Homecare Inc., a Philadelphia home healthcare provider, for $13.5 million in cash and shares, GlobeNewswire announced October 29, 2026. Davion is an Irish developer of non-invasive health monitoring technologies. HSH is a Pennsylvania-incorporated provider of skilled nursing, home health aide and rehabilitation services.
Davion's $13.5 Million Terms for HSH
The consideration comprises $8 million in cash and $5.5 million in Davion shares issued at an agreed value of $13 per share. Completion is expected on or before December 31, 2026, subject to the terms of the acquisition agreement.
HSH reported gross receipts of approximately $11.6 million and ordinary business income of approximately $1.9 million for the year ended December 31, 2025, on an unaudited basis. Davion said the acquisition is expected to provide an established operating business and an additional source of revenue and earnings following completion.
HSH provides care to patients of all ages in Philadelphia and surrounding areas, with clinical programmes including wound care, lymphedema management, dementia and diabetes care, telehealth and rehabilitation. According to its website, HSH holds JCAHO accreditation and Medicare and Medicaid certifications.
Glenn Williams, Chief Executive Officer of Davion, said: "HSH is an established and profitable business that will bring meaningful revenues and earnings to Davion, while giving us a direct presence in home healthcare and opportunities to introduce our monitoring and diagnostic technologies closer to patients."
Manilal Mathai, Co-owner and Chief Executive Officer of HSH, said: "Joining forces would give us an opportunity to combine HSH's home healthcare experience with Davion's technology-led approach, while continuing to focus on the quality and continuity of care we provide to patients and families."
What Davion's Company Records Show
Davion Healthcare's akta.pro company records list a September 2026 debt funding round of $40.4 million and a single funding round on record. The same records describe Davion as founded in 2024 and headquartered in Cork, Ireland, with 25,000,000 ordinary shares in issue.
Davion's Run of Deals Before HSH
In June 2026, Davion entered a share purchase agreement to acquire 100% of Humanoskan Ltd, a medical technology company, for $60 million, comprising $10 million in cash and $50 million in Davion shares at $13.00 per share, Aijourn reported. In September 2026, Davion Healthcare Finance Ltd had a £30 million senior secured bond admitted to trading on the Vienna MTF, with a five-year term and 10.5% fixed coupon, PR Newswire reported. In October 2026, Davion completed the acquisition of Humaskan's intellectual property for $25 million, including WoundSkan and Spektra, GlobeNewswire reported.
HSH Integration After Closing
The acquisition would extend Davion beyond healthcare products into care delivered in patients' homes. Davion said any integration or deployment plans will be developed following completion, and that the deal represents the first in a planned programme of acquisitions of profitable healthcare businesses over the coming year.